Purchase Order 75N92019P00417

The National Institute of Arthritis and Musculoskeletal and Skin Diseases issued a purchase order to Agilent Technologies Inc. on September 21, 2020, valued at $59,245.98 for a capillary electrophoresis instrument equivalent to the Agilent 5300 Fragment Analyzer System. The order carries no small business set-aside. Performance occurs at Bethesda, Maryland, with an ultimate completion date of January 30, 2021. The procurement originated from a solicitation posted September 2, 2020, with award...

This is a $149,984.51 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to Agilent Technologies Inc. for the purchase of a Seahorse XFe96 Analyzer. The NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) procured this equipment without full and open competition, citing the need for continuity of ongoing research projects related to APOL1. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied markets,...

This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Agilent Technologies Inc. Customer Service And Sales Division for a Seahorse XFE96 Analyzer 64-bit instrument. The award ceiling value is $268,318.98 and the contract completion date is November 30, 2020. No set-aside designation was used for this award. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied...

The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division to provide an AGILENT SEAHORSE XFE96 ANALYZER. The award, which did not have a set-aside designation, had a potential value of $149,781.75 and a completion date of August 22, 2017. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Agilent Technologies Inc. for $17,269.20 on June 23, 2017, for a Seahorse XF96 analyzer maintenance service plan with a firm fixed price structure.</p> <p>Performance occurs at Bethesda, Maryland. The order covers preventative maintenance and support services for analytical laboratory equipment, with an ultimate completion date of September 30, 2017. No set-aside category applies to this acquisition.</p>

This firm fixed price purchase order for $108,702 was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke to Agilent Technologies Inc. for a preventative maintenance and service agreement for an Agilent Technologies Seahorse XFe96 Analyzer (serial number 410250). The agreement is for a one year base period of performance from February 2023 through February 2028 and includes four one-year option periods. No...

The National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases has awarded a firm fixed price purchase order valued at $10,896 to Agilent Technologies Inc. for a one-year service contract supporting their Agilent 5300 Fragment Analyzer System. The contract will run from December 1, 2023 through December 31, 2024. Agilent Technologies Inc. will provide customer service and sales to support the genomic technology section's fragment analyzer located in...

The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded a $14,076.50 firm fixed price purchase order to Agilent Technologies Inc.'s Customer Service And Sales Division for maintenance service upgrade of a Seahorse XFE96 controller. The place of performance will be in Baltimore, Maryland. The upgrade services will be provided between September 27, 2023 and November 26, 2023 to support the National Institute on Aging's research programs....

<p>The U.S. National Institute of Diabetes and Digestive and Kidney Diseases awarded a $9,426.00 firm-fixed-price purchase order to Seahorse Bioscience, Inc. for time and materials repair and maintenance of the XF Analyzer. This award was not set aside. Seahorse Bioscience, Inc. is a for-profit manufacturer of goods. The award was made on July 17, 2015, with a completion date of July 20, 2015.</p>

This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Agilent Technologies Inc. to procure an Agilent Seahorse XFe96 Analyzer, a specialized instrument for measuring cellular metabolism. The contract has a firm fixed price of $164,253.00 and does not have a set-aside designation. The Agilent Seahorse XFe96 Analyzer will be used to support research activities at the National Cancer Institute. Agilent Technologies Inc....